Novel Bihormonal Artificial Pancreas Beneficial After Pancreatectomy
FRIDAY, Sept. 9, 2022 (HealthDay News) — Patients after total pancreatectomy receiving a novel, fully closed-loop bihormonal artificial pancreas (BIHAP) using both insulin and glucagon, experience significantly more time spent in euglycemia than thos…
Learn MoreAutomated Insulin Delivery Ups Time in Target Glucose Range in T1D
FRIDAY, Sept. 9, 2022 (HealthDay News) — Among patients with type 1 diabetes, percentage of time in the target glucose range is increased with the use of an open-source automated insulin delivery (AID) system, according to a study published in the Se…
Learn MorePreservation of C-Peptide Secretion Examined in Youth With T1D
THURSDAY, Sept. 8, 2022 (HealthDay News) — Intensive glucose control for 24 months does not slow the decline in residual C-peptide secretion among youth with new-onset type 1 diabetes, according to a study published in the Sept. 8 issue of the New En…
Learn MoreExperimental Insulin-in-a-Pill Shows Promise in Rat Study
MONDAY, Sept. 5, 2022 (HealthDay News) – People with type 1 diabetes who need to inject insulin a few times a day could eventually be switching to an easier-to-take tablet that dissolves inside the cheek. Canadian researchers working with rodents repo…
Learn MoreAsí bajará la Ley de Reducción de la Inflación el costo de la atención de la salud
MIÉRCOLES, 17 de agosto de 2022 (HealthDay News) — El Presidente Joe Biden firmó el martes la Ley de Reducción de la Inflación (Inflation Reduction Act), lo que la convierte en la legislación sobre atención de la salud más significativa que se ha apr…
Learn MoreHere’s How the Inflation Reduction Act Will Lower the Cost of Health Care
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — President Joe Biden on Tuesday signed the Inflation Reduction Act into law, making it the most significant health care legislation enacted in more than a decade. How will it affect health care?Millions of A…
Learn MoreDaily Insulin Dose Tied to Cancer Risk in Patients With T1DM
MONDAY, Aug. 1, 2022 (HealthDay News) — Daily insulin dose is associated with cancer risk among individuals with type 1 diabetes (T1D), according to a research letter published online July 28 in JAMA Oncology.Wenjun Zhong, Ph.D., from Merck Research …
Learn MoreCalifornia producirá su propia insulina para reducir precios
VIERNES, 8 de julio de 2022 (HealthDay News) — El gobernador de California, Gavin Newsom, anunció el martes que el estado gastará 100 millones de dólares para producir su propia insulina.La innovadora iniciativa llega tras años de precios astronómico…
Learn MoreCalifornia Will Produce Its Own Insulin to Bring Down Prices
FRIDAY, July 8, 2022 (HealthDay News) — California Governor Gavin Newsom announced Thursday that the state will spend $100 million to produce its own insulin.The innovative push comes after years of astronomical prices for the drug have made it nearl…
Learn MorePoll Finds Many Diabetes Caregivers Exhausted, Lacking Support
TUESDAY, July 5, 2022 (HealthDay News) — Diane Kondyra knows a lot about the hidden dangers of diabetes.Both she and her husband have been diagnosed with the blood sugar disease, and her husband suffered one of its devastating complications in 2018 w…
Learn More